statistiche ricercatore

Continente	#
NA - Nord America	830
AS - Asia	697
EU - Europa	482
SA - Sud America	110
AF - Africa	15
OC - Oceania	6
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.142

Nazione	#
US - Stati Uniti d'America	802
SG - Singapore	221
CN - Cina	202
IT - Italia	152
BR - Brasile	80
HK - Hong Kong	66
IE - Irlanda	58
VN - Vietnam	56
GB - Regno Unito	49
DE - Germania	39
IN - India	35
FI - Finlandia	33
BD - Bangladesh	32
FR - Francia	32
SE - Svezia	32
RU - Federazione Russa	26
KR - Corea	24
CA - Canada	17
ID - Indonesia	13
AR - Argentina	11
CO - Colombia	11
NL - Olanda	10
LT - Lituania	9
JP - Giappone	8
MX - Messico	8
ES - Italia	7
IQ - Iraq	7
AU - Australia	6
CZ - Repubblica Ceca	6
UA - Ucraina	6
AT - Austria	4
BG - Bulgaria	4
CL - Cile	4
PK - Pakistan	4
TR - Turchia	4
AE - Emirati Arabi Uniti	3
SA - Arabia Saudita	3
TN - Tunisia	3
UZ - Uzbekistan	3
ZA - Sudafrica	3
BE - Belgio	2
DZ - Algeria	2
EC - Ecuador	2
EU - Europa	2
KE - Kenya	2
MY - Malesia	2
PL - Polonia	2
RO - Romania	2
TH - Thailandia	2
TW - Taiwan	2
AL - Albania	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CH - Svizzera	1
CI - Costa d'Avorio	1
CY - Cipro	1
DJ - Gibuti	1
EG - Egitto	1
ET - Etiopia	1
GR - Grecia	1
HN - Honduras	1
HR - Croazia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LV - Lettonia	1
MA - Marocco	1
NP - Nepal	1
OM - Oman	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PT - Portogallo	1
PY - Paraguay	1
QA - Qatar	1
RS - Serbia	1
SK - Slovacchia (Repubblica Slovacca)	1
SY - Repubblica araba siriana	1
Totale	2.142

Nome	#
Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature.	350
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials.	338
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery.	255
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis	254
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis	224
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice	209
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting	182
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis	179
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib	163
Totale	2.154

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	6	0	0	0	0	0	0	0	0	0	0	0	6
2021/2022	107	0	22	10	1	6	7	4	11	10	5	20	11
2022/2023	201	16	31	13	15	6	22	1	13	64	2	7	11
2023/2024	142	6	6	15	15	20	14	6	20	3	11	14	12
2024/2025	527	18	9	16	43	96	69	43	27	61	29	52	64
2025/2026	1.093	94	55	105	88	112	78	148	60	126	87	79	61
Totale													2.154